GSA Capital Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-37,308
| Closed | -$1.47M | – | 2080 |
|
|
2024
Q3 | $1.47M | Buy |
37,308
+30,830
| +476% | +$1.21M | 0.11% | 232 |
|
|
2024
Q2 | $253K | Sell |
6,478
-15,136
| -70% | -$591K | 0.02% | 1361 |
|
|
2024
Q1 | $930K | Buy |
+21,614
| New | +$930K | 0.07% | 480 |
|
|
2023
Q2 | – | Sell |
-18,562
| Closed | -$664K | – | 1992 |
|
|
2023
Q1 | $664K | Buy |
18,562
+4,799
| +35% | +$172K | 0.07% | 540 |
|
|
2022
Q4 | $543K | Buy |
+13,763
| New | +$543K | 0.07% | 553 |
|
|
2016
Q2 | – | Sell |
-13,384
| Closed | -$94K | – | 1946 |
|
|
2016
Q1 | $94K | Sell |
13,384
-24,407
| -65% | -$171K | 0.01% | 1587 |
|
|
2015
Q4 | $304K | Sell |
37,791
-28,150
| -43% | -$226K | 0.01% | 1455 |
|
|
2015
Q3 | $545K | Buy |
65,941
+32,697
| +98% | +$270K | 0.03% | 1079 |
|
|
2015
Q2 | $383K | Buy |
33,244
+20,944
| +170% | +$241K | 0.01% | 1490 |
|
|
2015
Q1 | $207K | Buy |
+12,300
| New | +$207K | 0.01% | 1913 |
|